Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens, page-22

lazy mofo ... if you open the link they provide it states:
they are aiming to recruit 52
it has 4 arms:

• CF33-CD19 IT Administration Monotherapy
• CF33-CD19 IV Administration Monotherapy
• CF33-CD19 IT Administration in Combination with Blinatumomab
• CF33-CD19 IV Administration in Combination with Blinatumomab

All enrolled subjects will be treated with CF33-CD19 on Day 1 and 8 of Cycle 1 and then on Day 1 of each cycle thereafter. Subjects treated with the combination regimen will also receive blinatumomab as a 28-day continuous infusion
primary completion is proposed to run to September next year

these are critically ill people with life expectancy of at least 3 months. i read this as saying that IMU have 3 months to ensure the treatment is working.

drop the strike 2 bs, it's getting old.

anything else you want to be spoon fed?